Skip to main content
Erschienen in: High Blood Pressure & Cardiovascular Prevention 4/2023

26.07.2023 | Original article

A Randomized Controlled Trial of Blood Pressure Reduction Based on Disease Control Priorities 3 in Pakistan to Manage and Control Hypertension

verfasst von: Subhana Akber Khan, Assad Hafeez, Arif Zaka, Shahzad Ali Khan, Ahsen Ahmed, Farrah Pervaiz, Abdul Hameed Siddiqui

Erschienen in: High Blood Pressure & Cardiovascular Prevention | Ausgabe 4/2023

Einloggen, um Zugang zu erhalten

Abstract

Introduction

According to American Heart Association standards, hypertension is classified into three stages based on blood pressure measurements: essential hypertension, stage 1 hypertension, and stage 2 hypertension. The global target is to reduce the prevalence of high blood pressure by 25% by the year 2025. Worldwide, the prevalence of high blood pressure among men and women aged 18 and above reported to be 24% and 20%, respectively.

Aim

The aim of this study was to overall reduce high blood pressure of hypertensive patients to the recommended level of 140/90 mm of Hg through implementing a non-pharmacological and multi-component intervention based on Disease Control Priorities (3rd edition).

Methods

A randomized controlled trial in which a multi-component intervention for lowering high blood pressure was tested. This was pilot-tested for its acceptance, appropriateness, and relevance, explored through an earlier formative research and desk review conducted from the available evidence. A total of 240 study participants were enrolled after obtaining informed consent. Ethical approval was obtained from the Institutional Review Board of Health Services Academy and the trial was registered in clinicaltrials.gov number NCT04336631. SPSS software version 21 was used to enter and analyze the data.

Results

High blood pressure of hypertensive patients in a hospital setting during 03 months yielded –23.9 mm Hg of systolic blood pressure reduction (95% confidence interval, p ≤ 0.005). A significant reduction was observed in intervention group after delivering the intervention. Compared to patients in the usual care group, improved health outcomes were achieved for diet control, reducing salt intake and increased physical exercise. In the intervention group, the mean blood pressure among male hypertensive patients was 145/90 mm Hg and in female hypertensive patients, the mean blood pressure was recorded as 140/100 mm Hg.

Conclusion

High blood pressure was significantly reduced in hypertensive patients who adhered to a low salt diet, weight loss measures, and increased physical activity.
Literatur
5.
Zurück zum Zitat Foëx P, Sear JW. Hypertension: pathophysiology and treatment. Contin Educ Anaesth Crit Care Pain. 2004;4(3):71–5.CrossRef Foëx P, Sear JW. Hypertension: pathophysiology and treatment. Contin Educ Anaesth Crit Care Pain. 2004;4(3):71–5.CrossRef
7.
Zurück zum Zitat Bozkurt B, Aguilar D, Deswal A, Dunbar SB, Francis GS, Horwich T, Jessup M, Kosiborod M, Pritchett AM, Ramasubbu K, and Rosendorff C. Contributory Risk and Management of Comorbidities of Hypertension, Obesity, Diabetes Mellitus, Hyperlipidemia, and Metabolic Syndrome in Chronic Heart Failure: A Scientific Statement from the American Heart Association. Vol. 134, Circulation. Lippincott Williams and Wilkins; 2016. p. e535–78. Available from: https://www.ahajournals.org/doi/https://doi.org/10.1161/CIR.0000000000000450, retrieved on 27 February 2020. Bozkurt B, Aguilar D, Deswal A, Dunbar SB, Francis GS, Horwich T, Jessup M, Kosiborod M, Pritchett AM, Ramasubbu K, and Rosendorff C. Contributory Risk and Management of Comorbidities of Hypertension, Obesity, Diabetes Mellitus, Hyperlipidemia, and Metabolic Syndrome in Chronic Heart Failure: A Scientific Statement from the American Heart Association. Vol. 134, Circulation. Lippincott Williams and Wilkins; 2016. p. e535–78. Available from: https://www.ahajournals.org/doi/https://​doi.​org/​10.​1161/​CIR.​0000000000000450​, retrieved on 27 February 2020.
17.
Zurück zum Zitat Ishtiaq S, Ilyas U, Naz S, Altaf R, Afzaal H, and Muhammad SA. Assessment of the risk factors of hypertension among adult & elderly group in twin cities of Pakistan. Vol. 67. 2017. Available from: https://jpma.org.pk/PdfDownload/8428, retrieved on 27 July, 2019. Ishtiaq S, Ilyas U, Naz S, Altaf R, Afzaal H, and Muhammad SA. Assessment of the risk factors of hypertension among adult & elderly group in twin cities of Pakistan. Vol. 67. 2017. Available from: https://​jpma.​org.​pk/​PdfDownload/​8428, retrieved on 27 July, 2019.
22.
Zurück zum Zitat Saqlain, M, Riaz A, Malik MN, Khan S, Ahmed A, Kamran S, and Ali H. medicina Medication Adherence and Its Association with Health Literacy and Performance in Activities of Daily Livings among Elderly Hypertensive Patients in Islamabad, Pakistan. 2019; Available from: www.mdpi.com/journal/medicina, retrieved on 1 March, 2020. Saqlain, M, Riaz A, Malik MN, Khan S, Ahmed A, Kamran S, and Ali H. medicina Medication Adherence and Its Association with Health Literacy and Performance in Activities of Daily Livings among Elderly Hypertensive Patients in Islamabad, Pakistan. 2019; Available from: www.​mdpi.​com/​journal/​medicina, retrieved on 1 March, 2020.
24.
26.
Zurück zum Zitat Suvila K, McCabe EL, Lehtonen A, Ebinger JE, Lima JA, Cheng S, and Niiranen TJ. Early Onset Hypertension Is Associated With Hypertensive End-Organ Damage Already by MidLife. Hypertens (Dallas, Tex 1979). 2019 Jul 1;74(2):HYPERTENSIONAHA11913069. Available from: http://www.ncbi.nlm.nih.gov/pubmed/31256722, retrieved on 29 March, 2020. Suvila K, McCabe EL, Lehtonen A, Ebinger JE, Lima JA, Cheng S, and Niiranen TJ. Early Onset Hypertension Is Associated With Hypertensive End-Organ Damage Already by MidLife. Hypertens (Dallas, Tex 1979). 2019 Jul 1;74(2):HYPERTENSIONAHA11913069. Available from: http://​www.​ncbi.​nlm.​nih.​gov/​pubmed/​31256722, retrieved on 29 March, 2020.
27.
Zurück zum Zitat Volpe M, Gallo G, Modena MG, Ferri C, Desideri G, Tocci G, Board of the Italian Society of Cardiovascular Prevention Bellone Simonetta Bertolotti Marco Biffi Alessandro Consoli Agostino Corsini Alberto Nati Giulio Pirro Matteo Rubattu Speranza Trimarco Bruno de Kreutzenberg Saula Vigili Volpe Roberto. Updated recommendations on cardiovascular prevention in 2022: an executive document of the Italian Society of Cardiovascular Prevention. High Blood Pressure & Cardiovascular Prevention. 2022 Mar;29(2):91-102. Volpe M, Gallo G, Modena MG, Ferri C, Desideri G, Tocci G, Board of the Italian Society of Cardiovascular Prevention Bellone Simonetta Bertolotti Marco Biffi Alessandro Consoli Agostino Corsini Alberto Nati Giulio Pirro Matteo Rubattu Speranza Trimarco Bruno de Kreutzenberg Saula Vigili Volpe Roberto. Updated recommendations on cardiovascular prevention in 2022: an executive document of the Italian Society of Cardiovascular Prevention. High Blood Pressure & Cardiovascular Prevention. 2022 Mar;29(2):91-102.
28.
Zurück zum Zitat Tsai SY, Huang WH, Chan HL, Hwang LC. The role of smoking cessation programs in lowering blood pressure: A retrospective cohort study. Tobacco induced diseases. 2021;19. Tsai SY, Huang WH, Chan HL, Hwang LC. The role of smoking cessation programs in lowering blood pressure: A retrospective cohort study. Tobacco induced diseases. 2021;19.
30.
Zurück zum Zitat Khan SA, Hafeez A, Sikander S, Khan AW, Yasmin R. A systematic review on dietary approaches to stop hypertension (dash) to control raised blood pressure among hypertensive patients. Pak J Public Health. 2019;9(4):198–202.CrossRef Khan SA, Hafeez A, Sikander S, Khan AW, Yasmin R. A systematic review on dietary approaches to stop hypertension (dash) to control raised blood pressure among hypertensive patients. Pak J Public Health. 2019;9(4):198–202.CrossRef
31.
Zurück zum Zitat Ragot S, Beneteau M, Guillou-Bonnici F, Herpin D. Prevalence and management of hypertensive patients in clinical practice: Cross-sectional registry in five countries outside the European Union. Blood Press. 2016;25(2):104–16. Available from: http://www.ncbi.nlm.nih.gov/pubmed/26873621, retrieved on 31 July, 2019. Ragot S, Beneteau M, Guillou-Bonnici F, Herpin D. Prevalence and management of hypertensive patients in clinical practice: Cross-sectional registry in five countries outside the European Union. Blood Press. 2016;25(2):104–16. Available from: http://​www.​ncbi.​nlm.​nih.​gov/​pubmed/​26873621, retrieved on 31 July, 2019.
36.
Zurück zum Zitat Jafar TH, Hatcher J, Poulter N, Islam M, Hashmi S, Qadri Z, Bux R, Khan A, Jafary FH, Hameed A, Khan A. Community-based interventions to promote blood pressure control in a developing country. Ann Intern Med. 2009;151(9):593.CrossRefPubMed Jafar TH, Hatcher J, Poulter N, Islam M, Hashmi S, Qadri Z, Bux R, Khan A, Jafary FH, Hameed A, Khan A. Community-based interventions to promote blood pressure control in a developing country. Ann Intern Med. 2009;151(9):593.CrossRefPubMed
Metadaten
Titel
A Randomized Controlled Trial of Blood Pressure Reduction Based on Disease Control Priorities 3 in Pakistan to Manage and Control Hypertension
verfasst von
Subhana Akber Khan
Assad Hafeez
Arif Zaka
Shahzad Ali Khan
Ahsen Ahmed
Farrah Pervaiz
Abdul Hameed Siddiqui
Publikationsdatum
26.07.2023
Verlag
Springer International Publishing
Erschienen in
High Blood Pressure & Cardiovascular Prevention / Ausgabe 4/2023
Print ISSN: 1120-9879
Elektronische ISSN: 1179-1985
DOI
https://doi.org/10.1007/s40292-023-00589-y

Weitere Artikel der Ausgabe 4/2023

High Blood Pressure & Cardiovascular Prevention 4/2023 Zur Ausgabe

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

29.05.2024 Herzinfarkt Nachrichten

Bei Menschen mit Typ-2-Diabetes sind die Chancen, einen Myokardinfarkt zu überleben, in den letzten 15 Jahren deutlich gestiegen – nicht jedoch bei Betroffenen mit Typ 1.

Erhöhtes Risiko fürs Herz unter Checkpointhemmer-Therapie

28.05.2024 Nebenwirkungen der Krebstherapie Nachrichten

Kardiotoxische Nebenwirkungen einer Therapie mit Immuncheckpointhemmern mögen selten sein – wenn sie aber auftreten, wird es für Patienten oft lebensgefährlich. Voruntersuchung und Monitoring sind daher obligat.

GLP-1-Agonisten können Fortschreiten diabetischer Retinopathie begünstigen

24.05.2024 Diabetische Retinopathie Nachrichten

Möglicherweise hängt es von der Art der Diabetesmedikamente ab, wie hoch das Risiko der Betroffenen ist, dass sich sehkraftgefährdende Komplikationen verschlimmern.

TAVI versus Klappenchirurgie: Neue Vergleichsstudie sorgt für Erstaunen

21.05.2024 TAVI Nachrichten

Bei schwerer Aortenstenose und obstruktiver KHK empfehlen die Leitlinien derzeit eine chirurgische Kombi-Behandlung aus Klappenersatz plus Bypass-OP. Diese Empfehlung wird allerdings jetzt durch eine aktuelle Studie infrage gestellt – mit überraschender Deutlichkeit.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.